| Bardoxolone study terminated by safety monitoring committee. |
|
| Yahoo: Abbott Laboratories Inc said its partner, Reata Pharmaceuticals, was discontinuing a late-stage trial of their potential blockbuster treatment for chronic kidney disease and diabetes based on safety concerns raised by an independent safety committee. |